Quality improvement initiative to reduce Medical Adhesive Related Skin injury (MARSI) in very preterm babies admitted to neonatal intensive care unit.


Journal

BMJ open quality
ISSN: 2399-6641
Titre abrégé: BMJ Open Qual
Pays: England
ID NLM: 101710381

Informations de publication

Date de publication:
29 May 2024
Historique:
received: 25 11 2023
accepted: 02 05 2024
medline: 31 5 2024
pubmed: 31 5 2024
entrez: 30 5 2024
Statut: epublish

Résumé

Sick preterm neonates are most vulnerable to developing skin injuries. Despite sound knowledge and application of evidence-based practices for preventing medical adhesive-related skin injury (MARSI), the incidence of MARSI was 30 events per 1000 adhesive application days in our unit. We aimed to reduce the median MARSI rate from the existing 30 per 1000 MARSI days to <5 per 1000 MARSI over 5 months from June 2023 to October 2023. With the point-of-care quality improvement (QI) approach, a prospective study was planned to reduce the incidence of MARSI among sick very preterm newborns (<32 weeks gestational age) and eventually improve overall skin condition during hospital stay. Sequential Plan-Do-Study-Act cycles were implemented based on the identified risk factors recognised during recurring team discussions. We demonstrated a reduction in the MARSI rate from 30 events per 1000 adhesive applications (during baseline assessment) to zero events per 1000 adhesive applications at the end of the study period. It was temporally related to the assessment of skin risk stratification at admission using a validated tool, regular assessment of neonatal skin condition score based on the skin risk stratification, and reinforcement of MARSI prevention bundle by application of barrier spray. Awareness regarding 'skin injury prevention' bundles was continually generated among healthcare professionals. The MARSI rate remained <5 events per adhesive application in the sustenance phase over 6 months. Implementing evidence-based skin care practices resulted in a significant reduction in iatrogenic cutaneous injury events in very preterm neonates.

Identifiants

pubmed: 38816009
pii: bmjoq-2023-002697
doi: 10.1136/bmjoq-2023-002697
pii:
doi:

Substances chimiques

Adhesives 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Shrutiprajna Kar (S)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Veneza Zareen Lyngdoh Jarain (VZL)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Soumi Karmakar (S)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Usha Devi (U)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India dr.ushaa@gmail.com.
Department of Neonatology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry, India.

Tapas Kumar Som (TK)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Pankaj Kumar Mohanty (PK)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Tanushree Sahoo (T)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Jagdish Prasad Sahoo (JP)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Saranya Jeyaraman (S)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Sangeeta Acharya (S)

Department of Neonatology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH